CRGT - רווח נקי למניה (EPS TTM) Cortigent Medical

Cortigent, Inc. develops neural interfaces to restore motor control and vision for injured individuals. The rolling specific profit history confirms the dynamics of this process, where indicates the value of this parameter. High R&D barriers and unique microelectrode implantation methods provide the company with a technological edge. A stable operating environment is supported by the humanitarian status of biomedicine, which minimizes geopolitical risks.

Net income per share over 12 months measures the actual efficiency of capital by distributing total annual income among all security holders. The dynamics of this metric allow an investor to assess business growth rates regardless of share issuance. An analysis of net income per share over the last four quarters reveals the ability of Cortigent, Inc. (CRGT) to monetize its developments. This chart reflects the financial results of implementing neurostimulation systems into medical practice. The stability of the line confirms the successful commercialization of brain-computer interfaces.